Systemic diseases and drug usage in the patient and control groups
| Patient group (n (%)) | Control group (n (%)) | |
|---|---|---|
| Hypertension | 9 (45.0) | 9 (45.0) |
| Diabetes mellitus | 11 (55.0) | 11 (55.0) |
| Hypercholestrolaemia | 5 (25.0) | 7 (35.0) |
| Coronary artery disease | 2 (10.0) | 2 (10.0) |
| Other additional diseases | ||
| ASD | 0 (0.0) | 1 (5.0) |
| Asthma | 2 (10.0) | 2 (10.0) |
| Kidney insufficiency | 1 (5.0) | 0 (0.0) |
| Crohn's disease | 0 (0.0) | 1 (5.0) |
| Goitre | 0 (0.0) | 1 (5.0) |
| COPD, goitre | 1 (5.0) | 0 (0.0) |
| Osteoporosis | 1 (5.0) | 0 (0.0) |
| Psoriasis | 0 (0) | 1 (5.0) |
| CVD | 1 (5.0) | 0 (0.0) |
| Tuberculosis | 1 (5.0) | 0 (0.0) |
| Antihypertension drug usage | 9 (45.0) | 9 (5.0) |
| Oral antidiabetics | 10 (50.0) | 6 (30.0) |
| Antiaggregant usage | 6 (30.0) | 5 (25.0) |
ASD, atrial septal defect; COPD, chronic obstructive pulmonary disease; CVD, cerebrovascular disease.